EMEA-001986-PIP01-16
Key facts
Invented name |
Xofigo
|
Active substance |
radium (223Ra) dichloride
|
Therapeutic area |
Oncology
|
Decision number |
P/0178/2017
|
PIP number |
EMEA-001986-PIP01-16
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Bayer AG
Tel. +49 30300139003 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|